GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,671.00p
   
  • Change Today:
      4.60p
  • 52 Week High: 1,730.00
  • 52 Week Low: 1,418.00
  • Currency: UK Pounds
  • Shares Issued: 4,988.42m
  • Volume: 1,033,917
  • Market Cap: 83,357m
  • RiskGrade: 73

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.8% 4.8%
Div Cover 1.5 1.4
Op Mrgn 17.8% 24.3%
ROCE 64.2%  
Latest F'cast
P/E 14.0 14.4
PEG 2.1 n/a
Pr/Revenue 2.7 2.6
Pr/Book 22.6  
Latest F'cast
Revenue 2.1% 5.1%
PBT 36.2% 64.1%
EPS 6.8% -3.1%
DPS n/a -0.1%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 32,396.36 7,876.28 115.67p 14.4 n/a -3% 79.96p 4.8%
31-Dec-20 35,029.75 8,593.46 117.75p 14.2 7.9 +2% 80.01p 4.8%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

GSK submits regulatory file in Japan: Daprodustat 21-Aug-2019 08:00 RNS
Director/PDMR Shareholding 12-Aug-2019 15:45 RNS
EU approval for Nucala self-administration 01-Aug-2019 15:30 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
09-Aug-19 Transfer From Emma Walmsley 0.000p 7 0.00
09-Aug-19 Buy Emma Walmsley 1,674.34p 7 117.20
24-Jul-19 Buy Judy Lewent 3,295.29p 449 14,795.83

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,671.00p
Change Today 4.60p
% Change 0.28 %
52 Week High 1,730.00
52 Week Low 1,418.00
Volume 1,033,917
Shares Issued 4,988.42m
Market Cap 83,357m
RiskGrade 73

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.97% below the market average68.97% below the market average68.97% below the market average68.97% below the market average68.97% below the market average
18.64% above the sector average18.64% above the sector average18.64% above the sector average18.64% above the sector average18.64% above the sector average
Price Trend
67.45% above the market average67.45% above the market average67.45% above the market average67.45% above the market average67.45% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income
49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
7.85% above the market average7.85% above the market average7.85% above the market average7.85% above the market average7.85% above the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 14
Sell 0
Strong Sell 2
Total 19
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 08-Aug-19 16-May-19
Paid 10-Oct-19 11-Jul-19
Amount 19.00p 19.00p

Trades for 21-Aug-2019

Time Volume / Share Price
12:51 67 @ 1,671.00p
12:51 100 @ 1,671.00p
12:51 100 @ 1,671.00p
12:51 505 @ 1,670.89p
12:50 347 @ 1,671.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page